Cetuximab sarotalocan

DB19240InvestigationalProtein Based Therapies

Cetuximab sarotalocan is under investigation in clinical trial NCT03769506 (ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy) for the...

Mechanism: Pharmacologically active on Epidermal growth factor receptor
Curator reviewed
Also known as: Cetuximab-irdye 700dx conjugate
Code names: ASP-1929 · RM-1929

Resolves to

Compound

UNIIMG94W1I5XWCAS2166339-33-7

Targets

P00533EGFR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cetuximab sarotalocan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account